Fundraising Fox

BlossomHill Therapeutics

San Diego, US · Founded 2020 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

JJ
JINGRONG JEAN CUIExecutive Officer, Director
YL
YISHAN LIExecutive Officer, Director
JJ
Jingrong Jean CuiExecutive Officer, Director
LP
Li Peter YishanExecutive Officer, Director
GL
GEORGE LEEDirector
CG
CARL GORDONDirector
SA
SUNDEEP AGRAWALDirector
BC
BIHUA CHENDirector
TS
TIMOTHY STUBBSDirector

Investors · 1

Reported raises · per SEC filings

Form D private placements
$84.2MraisedDec 2025 · 47 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • GEORGE LEEDirector
  • CARL GORDONDirector
  • YISHAN LIExecutive Officer, Director
  • SUNDEEP AGRAWALDirector
  • BIHUA CHENDirector
  • TIMOTHY STUBBSDirector
  • JINGRONG JEAN CUIExecutive Officer, Director
Offering amount
$84.2M
Amount sold
$84.2M
First sale
Nov 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$88.6MraisedJan 2024 · 44 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Sundeep AgrawalDirector
  • Jingrong Jean CuiExecutive Officer, Director
  • Bihua ChenDirector
  • George LeeDirector
  • Carl GordonDirector
  • Yishan LiExecutive Officer, Director
  • Hongbo LuDirector
Offering amount
$100M
Amount sold
$88.6M
First sale
Dec 2023
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$71MraisedMar 2021 · 27 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • George LeeDirector
  • Li Peter YishanExecutive Officer, Director
  • Bihua ChenDirector
  • Carl GordonDirector
  • Jingrong Jean CuiExecutive Officer, Director
Offering amount
$71M
Amount sold
$71M
First sale
Mar 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$2MraisedJan 2021 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jingrong Jean CuiExecutive Officer, Director
  • Li Peter YishanExecutive Officer, Director
Offering amount
$2M
Amount sold
$2M
First sale
Dec 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.